Aims : The aim of this symposium is to highlight four areas of treatment in children and adults with cystic fibrosis that contain controversies and dilemmas, namely, the lung microbiome, newer anti-inflammatory therapies, nutrition, and adherence to treatment. Evidence that suggests how to resolve these problems will be described and discussed.